Mutlu Demiray (M Demiray)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Therapeutic advances in medical oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Medicana

Akdeniz Üniversitesi T?p Fakültes (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medicana Jun 25 2014

Turkey

oncology director :: medical oncology

Education History

Akdeniz Üniversitesi T?p Fakültes Sep 25 1989 - Jun 06 1994

Turkey

PHD

Publications

Esranur Aydın, Unal Metin Tokat, Eylül Özgü, Ashkan Adibi, Onur Tutar, Razelle Kurzrock, Mutlu Demiray
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations. Therapeutic advances in medical oncology 16 (2024)
Esranur Aydın, Unal Metin Tokat, Eylül Özgü, Ashkan Adibi, Onur Tutar, Razelle Kurzrock, Mutlu Demiray
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations. Therapeutic advances in medical oncology 16 (2024)
Esranur Aydın, Unal Metin Tokat, Eylül Özgü, Ashkan Adibi, Onur Tutar, Razelle Kurzrock, Mutlu Demiray
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations. Therapeutic advances in medical oncology 16 (2024)
Eylül Özgü, Esranur Aydın, Ashkan Adibi, Ünal Metin Tokat, Onur Tutar, Jiancheng Hu, Irem Demiray, Razelle Kurzrock, Mutlu Demiray
Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview. JCO precision oncology 7 (2023)
Ashkan Adibi, Unal Metin Tokat, Eylül Özgü, Esranur Aydın, İrem Demiray, Mutlu Demiray
PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview. Therapeutic advances in medical oncology 15 (2023)
Eylül Özgü, Esranur Aydın, Ashkan Adibi, Ünal Metin Tokat, Onur Tutar, Jiancheng Hu, Irem Demiray, Razelle Kurzrock, Mutlu Demiray
Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview. JCO precision oncology 7 (2023)
Eylül Özgü, Esranur Aydın, Ashkan Adibi, Ünal Metin Tokat, Onur Tutar, Jiancheng Hu, Irem Demiray, Razelle Kurzrock, Mutlu Demiray
Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview. JCO precision oncology 7 (2023)
Ashkan Adibi, Unal Metin Tokat, Eylül Özgü, Esranur Aydın, İrem Demiray, Mutlu Demiray
PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview. Therapeutic advances in medical oncology 15 (2023)
Mutlu Demiray
Combinatorial Therapy of High Dose Vitamin C and PARP Inhibitors in DNA Repair Deficiency: A Series of 8 Patients. Integrative cancer therapies 19 (2021)
F Bahadori, Mutlu Demiray
Management of extravasation of oxaliplatin by mimicking its biotransformation. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (10) (2018)
H Sahinbas, M Rosch, Mutlu Demiray
Temperature measurements in a capacitive system of deep loco-regional hyperthermia. Electromagnetic biology and medicine 36 (3) (2017)

Mutlu Demiray.css-eqlu8i{font-size:small;padding-left:4px;} (M Demiray)

Publication Activity (10 Years)

Top Topics

Top Venues

Mutlu Demiray (M Demiray)